ClinicalTrials.Veeva

Menu

The Features Behind the Beneficial Effects of Interval-walking (aIWS2)

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Diabetes Mellitus, Type 2

Treatments

Behavioral: IW3
Behavioral: Control
Behavioral: IW1

Study type

Interventional

Funder types

Other

Identifiers

NCT02257190
H-1-2014-060

Details and patient eligibility

About

A single bout of Interval-Walking (IW) exercise is superior to energy-expenditure and time-duration matched Continuous Walking (CW) exercise upon improving glycemic control. The reason IW is superior is unknown.

This study will look into whether it is the larger peak intensity during IW or if it is the alternating exercise pattern that is responsible for the larger improvements seen.

Subjects with type 2 diabetes will be included in a crossover, counter-balanced, controlled study, where each subject will undergo three trials. Trials will be identical except the following interventions:

  1. One hour of rest (Con)
  2. One hour of classical interval walking (repeated cycles of 3 min of fast and 3 min of slow walking; IW3)
  3. One hour of fast alternating interval walking (repeated cycles of 1 min of fast and 1 min of slow walking; IW1).

After the interventions subjects will undergo a standardized mixed meal tolerance test, with consecutive measurements of blood glucose, insulin and c-peptide.

Enrollment

12 patients

Sex

All

Ages

30+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type 2 diabetes mellitus
  • Body mass index > 18 but < 40 m2/kg
  • Agreement to pause antidiabetic medication from 2 days before to after each trial

Exclusion criteria

  • Pregnancy
  • Smoking
  • Use of exogenous insulin
  • Contraindication to increased levels of physical activity
  • Evidence of thyroid, liver, lung, heart or kidney disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

12 participants in 3 patient groups

Control (Con)
Experimental group
Description:
No exercise intervention.
Treatment:
Behavioral: Control
Interval Walking - 3 min intervals (IW3)
Experimental group
Description:
One hour of classical interval walking exercise (repeated cycles of 3 min of fast and 3 min of slow walking.
Treatment:
Behavioral: IW3
Interval Walking - 1 min intervals (IW1)
Experimental group
Description:
One hour of fast alternating interval walking exercise (repeated cycles of 3 min of fast and 3 min of slow walking
Treatment:
Behavioral: IW1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems